Adjuvants in IVF—evidence for what works and what does not work

Abstract

The field of assisted reproductive technology is shaped and changed constantly by advances in science and cutting-edge innovations. In a quest to maximise outcomes, add-on interventions are often adopted and utilised prematurely while the principles of evidence-based medicine seem to be less strictly adhered to. In this review we will attempt to summarise the latest evidence about some of the adjuvants.

Keywords:

• Adjuvant therapy
• IVF

Disclosure statement

The authors do not have any financial interest in commercial products or services related to the subject of this paper.

Additional information

Notes on contributors

Luciano Nardo

Luciano Nardo, MD MRCOG, is a consultant gynaecologist and RCOG subspecialist in reproductive medicine and surgery. He is visiting professor at Manchester Metropolitan University and clinical director at the Reproductive Health Group. Dr Nardo is member of many professional societies and advisory boards.

Spyridon Chouliaras

Spyridon Chouliaras, MD, DFFP, FRCOG, is an obstetrician and gynaecologist specialised in infertility and IVF. He is an assistant professor of Clinical Obstetrics and Gynaecology at Weill Cornell Medicine-Q, and an attending physician in Reproductive Medicine at Sidra Medicine, Qatar.